Society of Diabetic Nephropathy Prevention Journal of Nephropathology 2251-8363 13 2 2024 03 10 Cancer-associated glomerulopathy; an updated review on current knowledge e22539 e22539 10.34172/jnp.2024.22539 EN Mozhgan Dahmardnezhad https://orcid.org/0009-0006-9397-7567 Tina Foodeh Sholeh Afshinpoor Nastaran Fooladivanda https://orcid.org/0000-0002-3027-4649 Journal Article 10.34172/jnp.2024.22539 2023 12 31 2024 02 16 Cancer-associated glomerulopathy (CAG) is a rare type of glomerular disease and a complication of malignancy. It is not absolutely related to the tumor burden, invasion, or metastasis however is supposed to be caused by tumor cell products. The recognition of cancer-related glomerulopathy is clinically crucial because it can be the first sign of an underlying malignancy. The most common glomerular diseases which are caused by malignancy are paraneoplastic glomerulopathy. Moreover, membranous nephropathy is the most common glomerular pathology associated with solid tumors.